Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Leaders Converge on Capitol Hill

Staff  |  Issue: February 2013  |  February 1, 2013

ACR volunteer leaders will be on Capitol Hill this month meeting face to face with key decision makers and discussing legislative and regulatory issues that affect the rheumatology community. The ACR Advocacy Leadership Conference takes place every spring in Washington, D.C. The conference is attended by members of the ACR Government Affairs Committee, RheumPAC Committee, and the Affiliate Society Council. In-person meetings with members of Congress are a critical piece of ACR’s advocacy program. These meetings support our efforts to influence national healthcare policy and ensure that policy makers are educated on the importance of the rheumatology subspecialty.

During the 2013 Advocacy Leadership Conference, the ACR is focused on educating recently elected members of Congress on our legislative priorities, including physician payment reform, patient access to treatment, and funding for medical research. While Congress passed a one-year fix to temporarily avert physician payment cuts at the end of 2012, the ACR is urging Congress to permanently replace the flawed SGR system that leads to this deepening annual crisis. The new model must recognize through appropriate reimbursement the specialized care rheumatologists provide.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

ACR advocates are also urging members of Congress to co-sponsor the Patients’ Access to Treatment Act of 2013. This bipartisan legislation, introduced by Representatives David McKinley (R-WV) and Lois Capps (D-CA), would place specialty-tier drugs, including biologics used to treat arthritis and other rheumatic diseases, within the confines of Tier III nonpreferred drugs. This move would mean that commercial health insurers would impose the same co-payment obligations for specialty drugs as they already do for Tier III medications. This critical legislation will help more patients to adhere to necessary treatment regimens by reducing the cost-sharing barriers to treatment.

Calling All Advocates—Meet with your Elected Officials at Home!

Meeting with members of Congress in Washington, D.C. is an important and effective way to convey the ACR’s legislative priorities to elected officials. However, you don’t have to travel to Washington to get involved. Members of Congress have regularly scheduled district work periods when they take time to meet with constituents in their local district offices. The ACR encourages you to schedule a district meeting to help educate your legislators and ensure the viability of the rheumatology subspecialty. For information on district work period schedules or assistance setting up a meeting, please contact [email protected] or call (404) 633-3777 to speak with ACR government affairs staff. ACR staff can handle the logistics of the meeting for you, so you can focus on your message to your representative. Your engagement is critically important and appreciated.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 | Multi-Page
Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:AC&RAdvocacyLegislationregulatory

Related Articles

    How Rheumatologists Can Win Support and Influence Congress

    April 1, 2013

    Ways to use the ACR’s advocacy toolkit to contact Congressional representatives and articulate your message to lawmakers

    Fellows’ Forum: Why Rheumatology Fellows Should Get Involved with Advocacy

    May 16, 2017

    Introduction Interest in rheumatology continues to grow, with more than 240 new adult and pediatric fellows to begin their training in the coming academic year. Given the broad and diverse career opportunities, it is an ACR goal to help guide trainees in their career decisions and professional development. Rheumatology fellowship often marks the transition from…

    ACR Leaders to Converge on Capitol Hill

    February 3, 2012

    In early March, leading members of Congress and other key policymakers will meet face to face with volunteer leaders of the ACR.

    ACR Board of Directors Advocates for Rheumatology on Capitol Hill

    May 1, 2013

    Members meet with Congress this month to discuss access to rheumatology, access to treatments, and funding for research

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences